[ConservativeMind]

There are ways to address senescent cells. Senolytics are medicines and supplements that can make dysfunctional cells “blow up,” through apoptosis. Some natural forms of that are fisetin, apagenin, and quercetin—all in a higher dose, though. The study’s choice of senolytic is not described, due to being behind a paywall, but it worked.

Another approach to consider would be to rehabilitate the dysfunctional cells, by reducing their inner inflammation and forcing their energy producers to rehabilitate themselves, via mitophagy (blowing up dysfunctional mitochondria and replacing them with brand new ones). This latter approach can be achieved with GlyNAC and Urolithin A, which are both available Over-The-Counter (OTC) as supplements.

Whether any of the above would directly work with the liver/bile duct cancer mentioned in the study write up is an unknown, but IL-6 is greatly blocked by GlyNAC and Urolithin A, and the antioxidants for apoptosis, along with many other antioxidants and even minerals, decrease IL-6, too, in studies.

It seems people with this cancer have a very poor prognosis, even with the best available medicines and therapies, so if out of options, perhaps one could consider trying them.

As always, consult with your doctor.

[ConservativeMind]

The “Take Charge Of Your Health” Ping List
This high volume ping list is for health articles and studies which describe something you or your doctor, when informed, may be able to immediately implement for your benefit.

Email me to get on either the “Common/Top Issues” (20% fewer pings) or “Everything” list.

[JusPasenThru]

Bookmarked.

[oblomov]

So Actemra and Sylvant (approved IL-6 inhibitors) could be used to treat this form of liver cancer?

[telescope115]

As much as we complain about “shrimp on treadmills” and other silly ways researchers spend money, there are a lot of worthwhile studies being done, yielding valuable information.

[Cottonbay]

Bttt